Skip to content

Clinical trials

Completed Dyslipidemias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: United States Clear all

268 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20022
20038
20045
200518
200626
200717
200822
20097
201016
201116
201213
20138
201415
20154
201612
20178
201811
20197
202010
20215
20227
20236
20248
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed268

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca20
Takeda20
UCSF Benioff Children's Hospital Oakland10
Pfizer9
Eli Lilly and Company8
Abbott7
Amgen7
National Heart, Lung, and Blood Institute (NHLBI)6
NewAmsterdam Pharma6
Tufts University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias268
Diabetes Mellitus50
Hypertension50
Hypercholesterolemia45
Hyperlipidemias43
Obesity40
Diabetes Mellitus, Type 235
Cardiovascular Diseases34
Metabolic Syndrome23
Insulin Resistance22

Trials

Showing 1 to 25 of 268. Each trial links to its page on Pharma Observatory.

168 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.